• 1
    Thomson A, Lunan C, Cameron A, Cameron I, Greer I, Norman J. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynaecol 1997;104: 10541057.
  • 2
    Chanrachakul B, Herabutya Y, Punyavachira P. Randomised comparison of glyceryl trinitrate and prostglandin E2 for cervical ripening at term. Obstet Gynecol 2000;96: 549553.
  • 3
    Nicoll A, Mackenzie F, Greer I, Norman J. Vaginal application of the nitric oxide donor isosorbide mononitrate for pre-induction cervical ripening: a randomised controlled trial to determine effects on maternal and fetal haemodynamics. Am J Obstet Gynecol 2001;184: 958964.
  • 4
    Abshagen U. Pharmacokinetics of isosorbide mononitrate. Am J Cardiol 1992;70: 61G66G.
  • 5
    Bulletti C, de Ziegler D, Flamigni C, et al. Targeted drug delivery in gynaecology: the first uterine pass mechanism. Hum Reprod 1997;12: 10731079.
  • 6
    Thomson A, Lunan C, Ledingham M, et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first trimester termination of pregnancy. Lancet 1998;352: 10931096.
  • 7
    Iversen HK, Nielsen TH, Garre K, Tfelt-Hansen P, Olesen J. Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol 1992;42: 3135.
  • 8
    Ekerhovd E, Brannstrom M, Alexandersson M, Nortstrom A. Evidence for nitric oxide mediation of contractile activity in isolated strips of the human fallopian tube. Hum Reprod 1997;12: 301305.
  • 9
    Denison F, Calder A, Kelly R. The action of prostaglandin E2 on the human cervix: stimulation of interleukin-8 and inhibition of leukocyte protease inhibitor. Am J Obstet Gynecol 1999;180: 614620.
  • 10
    Ledingham M, Thomson A, Greer I, Norman J. Nitric oxide in pregnancy and parturition. Br J Obstet Gynaecol 2000;107: 581593.